Pembrolizumab
Merck
['lcsm,(-blcsm)', 'pearls', 'pearl']
interesting presentation by on the unexpected results of the pd-l1 &gt;50% subgroup of the adjuvant pearls trial. higher than expected rfs in the placebo arm could be in cause #lcsm #esmo22
Med onc and hematologist at @chudequebec with focus on lung cancer. Tweets in English for sake of conversation, mais toujours heureux de parler français!